Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
Abstract Background Hypertension and/or myocardial infarction are common causes of heart failure in Type 2 diabetes. Progression to heart failure is usually preceded by ventricular dysfunction, linked to matrix metalloproteinase (MMP) mediated extracellular matrix changes. We hypothesise that the mi...
Main Authors: | Chris Watson, J. Paul Spiers, Max Waterstone, Adam Russell-Hallinan, Joseph Gallagher, Kenneth McDonald, Cristin Ryan, John Gilmer, Mark Ledwidge |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-021-01860-7 |
Similar Items
-
Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease
by: Yuanyuan Xu, et al.
Published: (2017-04-01) -
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
by: Saray Quintero-Fabián, et al.
Published: (2019-12-01) -
Multifaceted role of Matrix Metalloproteinases (MMPs)
by: Divya eSingh, et al.
Published: (2015-05-01) -
Expression of matrix metalloproteinases in diffuse gliomas: diagnostic value
by: T. V. Shynkarenko
Published: (2017-08-01) -
LONG-TERM TREATMENT RESULTS OF BONE SARCOMA PATIENTS WITH CONSIDERATION OF SERUM METALLOPROTEINASE LEVELS
by: I. V. Babkina, et al.
Published: (2016-02-01)